Massachusetts S1479 clarifies prescription monitoring program activities by excluding testosterone from the list of monitored drugs.
Massachusetts S1479 amends the state's prescription monitoring program to exclude testosterone from the list of drugs tracked. The bill also mandates the immediate deletion of any existing data related to testosterone prescribing and dispensing from the system. This change aims to refine the scope of the prescription monitoring program, focusing on other substances while exempting testosterone from surveillance.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.